{"entity":{"id":"hsa-singapore","kind":"institution","name":"Health Sciences Authority, Singapore","aka":["HSA","HSA Singapore"],"tldr":"Singapore's medicines regulator. It registers a new medicine by full evaluation, by abridged evaluation if at least one regulator has approved it, or by verification if at least two of its six reference agencies have.","summary":"The Health Sciences Authority registers therapeutic products in Singapore. Its evaluation routes page describes three routes for a new drug: full evaluation for a product no regulator has approved; abridged evaluation for a product approved by at least one drug regulatory agency; and verification for a product approved by at least two of its reference agencies (the US FDA, the European Medicines Agency through the centralised procedure, Health Canada, the UK MHRA, Swissmedic and Australia's TGA), within three years by the chosen primary agency, with the unredacted assessment reports. A company may ask for priority review for a medicine for a serious life-threatening condition that meets a local unmet need, and the page names cancer among the conditions of local public health concern. The Ministry of Health's financing FAQs say a drug generally counts as clinically proven for the Cancer Drug List if it is registered with the authority for the indication.","asOf":"2026-11-11","links":[{"label":"HSA: evaluation routes for therapeutic products","url":"https://www.hsa.gov.sg/therapeutic-products/registration-of-therapeutic-products/register-your-therapeutic-product/registration-of-therapeutic-products/evaluation-routes/"},{"label":"Ministry of Health: FAQs on cancer treatment financing","url":"https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/medishield-life/faqs-on-cancer-treatment-financing/"},{"label":"FDA: Project Orbis partners, including Singapore's HSA","url":"https://www.fda.gov/about-fda/oncology-center-excellence/project-orbis"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["ministry-of-health-singapore"],"pathways":[],"terms":["project-orbis"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Singapore","country":"SG","lat":1.28,"lng":103.84,"institutionType":"government","website":"https://www.hsa.gov.sg","programs":["Full, abridged and verification evaluation routes","Priority review","Project Orbis participation"]},"route":"/institutions/hsa-singapore/","neighbours":{"institution":[{"id":"ministry-of-health-singapore","kind":"institution","name":"Ministry of Health, Singapore","route":"/institutions/ministry-of-health-singapore/"}],"term":[{"id":"project-orbis","kind":"term","name":"Project Orbis","route":"/terms/project-orbis/"}]}}